Current Pharmaceutical Biotechnology

Peer-review medical journal.

 

Publisher

Bentham Science (https://www.benthamscience.com/)

Editor-in-Chief

Nikolaos E. Labrou, Department of Biotechnology Agricultural University of Athens, Athens (Greece)
ORCID: https://orcid.org/0000-0003-1925-9867

Indexing

Abstracted & Indexed in:

Biological Abstracts, BIOSIS Previews, British Library, Cabell's Directory/Journalytics, Cambridge Scientific Abstracts (CSA)/ProQuest, Chemical Abstracts Service/SciFinder, CNKI Scholar, Current Contents® - Life Sciences, EBSCO, EMBASE, EMBiology, ERA 2018, Essential Science Indicators, Genamics Journal Seek, Google Scholar, Index Copernicus, Index Medicus, J-Gate, Journal Citation Reports/Science Edition, JournalTOCs, MediaFinder®-Standard Periodical Directory, MEDLINE/PubMed, Norwegian Register, OpenAire, PubsHub, QOAM, Science Citation Index Expanded™ (SciSearch®), Science Gate, Scilit, Scopus, Suweco CZ, Ulrich's Periodicals Directory

Archiving and Copyright:

Portico, Sherpa Romeo

Journal Database:

Dimensions

 

About

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal includes timely in-depth/ mini-reviews, original research articles, and letters written by leaders in the field, covering a range of current topics in scientific areas of Pharmaceutical Biotechnology. Invited and unsolicited review articles are welcome. The journal encourages contributions describing research at the interface of drug discovery and pharmacological applications, involving in vitro investigations and pre-clinical or clinical studies. Scientific areas within the scope of the journal include pharmaceutical chemistry, biochemistry and genetics, molecular and cellular biology, and polymer and materials sciences, as they are related to pharmaceutical science and biotechnology. In addition, the journal also considers comprehensive studies and research advances pertaining to food chemistry with pharmaceutical implications. Areas of interest include:

●     DNA/protein engineering and processing
●     Synthetic biotechnology
●     Omics (genomics, proteomics, metabolomics, and systems biology)
●     Therapeutic biotechnology (gene therapy, peptide inhibitors, and enzymes)
●     Drug delivery and targeting
●     Nanobiotechnology
●     Molecular pharmaceutics and molecular pharmacology
●     Analytical biotechnology (biosensing, advanced technology for detection of bioanalytes)
●     Pharmacokinetics and pharmacodynamics
●     Applied Microbiology
●     Bioinformatics (computational biopharmaceutics and modeling)
●     Environmental biotechnology
●     Regenerative medicine (stem cells, tissue engineering, and biomaterials)
●     Translational immunology (cell therapies, antibody engineering, and xenotransplantation)
●     Industrial bioprocesses for drug production and development
●     Biosafety
●     Biotech ethics

Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome.

Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government, and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

Current Pharmaceutical Biotechnology is an international, peer-reviewed journal on all the developments in pharmaceutical biotechnology, published biweekly (print & online) by Bentham Science Publishers.

 

Subscription 

Subscription (to get access, please, follow the link: https://journals.eco-vector.com/1389-2010/about/subscriptions)